Posts

Showing posts from February, 2024

Particle Counters Market worth $825 million by 2027

Image
  According to a research report " Particle Counters Market   by Type (Airborne, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquid, Aerosol Monitoring), End User (Life Sciences & Medical Devices, Semiconductor), Region - Global Forecasts to 2027" published by MarketsandMarkets, the global particle counters market is estimated to reach USD 825 million by 2027 from USD 511 million in 2022, at a CAGR of 10.0% from 2022 to 2027. Factors such as robust growth in applied markets, the favourable regulatory scenario, and growing focus on the quality of food products are driving the growth of the particle counters market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221564539 Browse in-depth TOC on '   Airborne Particle Counters Market' 151 – Tables 29 – Figures 197 – Pages Key Market Players: Particle Measuring Systems (US), Beckman Coulter (US), RION Co., Ltd. (Jap

Point of Care/ Rapid Diagnostics Market worth $75.5 billion by 2027

Image
 According to the new market research report published by MarketsandMarkets, " Point of Care Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027", the global point of care diagnostics market in terms of revenue was estimated to be worth $45.4 billion in 2022 and is poised to reach $75.5 billion by 2027, growing at a CAGR of 10.7% from 2022 to 2027. Browse in-depth TOC on "Point of Care Diagnostics Industry" 334 - Tables 48 - Figures 398 – Pages ​ Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The high prevalence of diabetes, cardiovascular diseases, infectious diseases and other target conditions, the increased number of CLIA-waived POC tests, increased focus of players in strengthening the POCT product portfolio, initiatives by government to boos

Global Orthopedic Braces and Supports Market Size Worth $4.6 billion by 2027

Image
 According to the new market research report " Orthopedic Braces and Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Rigid, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Pharmacies) & Region - Global Forecast to 2027", published by MarketsandMarkets™, the global Orthopedic Braces and Supports Market is estimated to reach USD 4.6 billion by 2027 from USD 3.4 billion in 2022, at a CAGR of 5.8% during the forecast period. Browse in-depth TOC on " Orthopedic Braces and Supports Industry " 163 – Tables 45 – Figures 337 – Pages ​ Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24806829 The Growth in the orthopedic braces and supports Market is mainly driven by the increasing prevalence of orthopedic diseases & disorders, continuous product commercialization, greater product affordability and market availability, rising number of sports and acciden

Lateral Flow Assay Market worth $16.8 billion by 2029

Image
  The   Global Lateral Flow Assays Market   in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising adoption of kits & reagents and lateral flow assay readers for infectious diseseas testing, veterinary diagnostics, and drug of abuse testing, cardiac marker testing. Whereas most of lateral flow assays are having limitation of qualitative detection, lot to lot variation like factors may hinder the growth of market during the forecast period. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133 Browse in-depth TOC on "Lateral Flow Assays Market" 420 - Tables 59 - Figu

Foot and Ankle Devices Market worth $5.3 billion by 2025

Image
  The   Global Foot and Ankle Devices Market   in terms of revenue was estimated to be worth $3.9 billion in 2020 and is poised to reach $5.3 billion by 2025, growing at a CAGR of 6.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market growth is driven by greater disease burden for key risk groups, emergence of user-centric foot and ankle devices, and rising demand for minimally invasive surgical procedures. However, the risk associated with surgical site infection is expected to limit market growth in the coming years. Browse in-depth TOC on "   Foot and Ankle Devices Industry" 280- Tables 38- Figures 310- Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=845 The growth of this market is mainly driven by the growi

Humanized Mouse and Rat Model Market worth $349 million by 2028

Image
  In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical research and drug development. These cutting-edge models, where mice and rats are genetically modified to possess human-like characteristics and immune systems, will play a pivotal role in bridging the gap between preclinical studies and clinical trials. Through refined genetic engineering techniques, these models will closely mimic human physiology, enabling more accurate and predictive assessments of drug safety, efficacy, and disease mechanisms. Moreover, the industry will witness the integration of advanced technologies, such as CRISPR/Cas9, to expedite the creation of customized humanized models, tailoring them to specific diseases or individual patient profiles. These advancements will spur collaboration between academia, pharmaceutical companies, and biotech firms, fostering a dynamic research ecosystem focused on targeted therapies and perso